Attollent Pharmaceuticals Private Limited
About Attollent Pharmaceuticals Private Limited
Data last updated:
Attollent Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 18 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2011PTC219321. Its GSTIN is 07AAJCA4650L2ZF (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Rishi Bhagawat Dayal and Santosh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.11 & 12 Kh. No.147 1st Floor Burari Garhi Village Burari, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.18 Cr, a growth of 76% compared to the previous year. For the same year it recorded a net profit of ₹14.06 Lakh (net margin 4.4%) and EBITDA of ₹21.04 Lakh (EBITDA margin 6.6%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Attollent Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No.11 & 12 Kh. No.147 1st Floor Burari Garhi Village Burari, Delhi, India – 110084
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Attollent Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Attollent Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Attollent Pharmaceuticals Private Limited, buy the company report.
Financials of Attollent Pharmaceuticals Private Limited
FY 2025 filings availableAttollent Pharmaceuticals Private Limited reported revenue of ₹3.18 Cr (up 76% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 76% in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Attollent Pharmaceuticals Private Limited, buy the company report.
Board of directors of Attollent Pharmaceuticals Private Limited
Attollent Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishi Bhagawat Dayal | Director | 18 Nov 2023 | 2 Years 11 Months | Current |
| Santosh | Director | 30 Apr 2022 | 4 Years 5 Months | Current |
| Sachin Kumar Bahot | Director | 13 Mar 2025 | 1 Years 7 Months | Current |
Auditor
Attollent Pharmaceuticals Private Limited is audited by ANAND KESARI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANAND KESARI & CO | FY 2023 | 500121N |
Shareholding
The shareholding of Attollent Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Attollent Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jul 2025 | 101136752 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Attollent Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Attollent Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Attollent Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCA4650L2ZF | Delhi | Active | 01 Jun 2022 |
To see the full GST registrations and return filing status of Attollent Pharmaceuticals Private Limited, buy the company report.
Recent activity
Attollent Pharmaceuticals Private Limited has 9 board changes on record since 2012: 4 appointments and 5 cessations. The latest: Sachin Kumar Bahot was appointed as Director on 13 Mar 2025.
1 earlier event is in the company report.
Frequently asked questions
Attollent Pharmaceuticals is an active private limited company based in Delhi, India. The company works in retailers, within the trading industry. It was incorporated on 18 May 2011 (15+ years old) and is registered under CIN U85100DL2011PTC219321.
Attollent Pharmaceuticals has 3 current directors:
- Rishi Bhagawat Dayal - Director
- Santosh - Director
- Sachin Kumar Bahot - Director
The latest financial statements of Attollent Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Attollent Pharmaceuticals is 07AAJCA4650L2ZF, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Attollent Pharmaceuticals is U85100DL2011PTC219321. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Attollent Pharmaceuticals was incorporated on 18 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Sachin Kumar Bahot was appointed as Director on 13 Mar 2025. Sri Niwas Bahot ceased to be Director on 06 Feb 2025. Rishi Bhagawat Dayal was appointed as Director on 18 Nov 2023. Attollent Pharmaceuticals has 9 board changes on record in total.
The registered office of Attollent Pharmaceuticals is at House No.11 & 12 Kh. No.147 1st Floor Burari Garhi Village Burari, Delhi, India – 110084.
Attollent Pharmaceuticals operates in the trading industry, in the retailers segment.
Attollent Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.